Bharat Biotech
A panel of experts of the Central Drugs Authority has reviewed the results of the Phase 3 study of Covaxin. Covaxin was developed by Bharat Biotech and the committee has approved the findings. Bharat Biotech Hyderabad has revealed the final analysis of Covaxin's effectiveness rate in the third stage of clinical trials. On the second of June, 2021 Bharat Biotech told that the overall efficacy rate of Covaxin was 77.8 percent to treat symptomatic infections. Bharat Biotech Phase 3 results Bharat Biotech has released its Phase 2 results of tests they conducted with Covaxin. The company has presented the results to an expert panel and the results were accepted from the group. This article will give you all information you need to know about Bharat Biotech Covaxin's phase III clinical trials. The most recently tweeted tweet, on the 2 July, the co-founder of the country said that they were extremely happy with the research team that h...